Optimization of the Dosage Regimen of Growth Hormone Therapy in Children Born Small for Gestational Age

NCT00249821 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

22

Enrollment

INDUSTRY

Sponsor class

Conditions

Small Gestational Age (SGA)

Interventions

DRUG: Saizen®
DRUG: Saizen®

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]